Not in the simple sense of being a scheduled or illegal substance. BPC-157 is a research-use-only compound. In 2023 the FDA's review of substances nominated for pharmacy compounding kept BPC-157 off the 503A Bulks List for human-use compounding, citing safety and characterisation concerns - which is what many headlines described as a 'ban.' It remains available as a laboratory research reagent, and it returns for FDA advisory committee discussion in July 2026.

Shop by goal

Popular compounds

Research resources

Is BPC-157 Banned? What the FDA Has and Hasn’t Done

Q: Did the FDA ban BPC-157 in 2023?

The FDA did not approve BPC-157 for compounding use in humans; its 2023 review effectively kept it off the 503A Bulks List, restricting compounding pharmacies from preparing it for people. That is different from criminalising the molecule. Research-grade BPC-157 supplied as a labelled reagent is a separate, non-human-use category.

Q: Is BPC-157 banned in sport?

Yes. The World Anti-Doping Agency (WADA) prohibits BPC-157 at all times under category S0 (non-approved substances) of its Prohibited List. Athletes in tested sport can face sanctions for its use, regardless of its research-compound status.

Short answer: not in the way the word suggests. BPC-157 is a research-use-only compound, not a scheduled or criminalised substance. In 2023 the FDA’s compounding review kept BPC-157 off the 503A Bulks List for human-use compounding — the decision behind most “BPC-157 banned” headlines. It remains available as a laboratory reagent, it returns for FDA advisory committee discussion in July 2026 , and it is separately prohibited in tested sport by WADA.

“Is BPC-157 banned?” is a question shaped almost entirely by headlines, and the headlines compress a lot of nuance into one scary word. The accurate picture is more specific: BPC-157 was never approved as a medicine, a 2023 FDA decision limited its use in pharmacy compounding, and it sits in a research-use-only category today. Here is what actually happened.

BPC-157 is not a controlled substance

First, the most common misunderstanding: BPC-157 is not a scheduled drug like a narcotic. There is no blanket criminal “ban” on the molecule itself. It is supplied to laboratories as a research reagent, labelled research use only, not for human consumption. As with most research compounds, the legal line is determined by how it is marketed and used — selling or labelling it for human use is what creates regulatory exposure — not by mere possession of a labelled reagent. Our explainer on whether peptides are legal sets out that distinction.

The 2023 FDA compounding decision (the real story behind “banned”)

The source of most “BPC-157 banned” coverage is the FDA’s 2023 evaluation of substances nominated for use in pharmacy compounding. In that review, BPC-157 was not placed on the 503A Bulks List for human-use compounding; the agency raised concerns including limited safety characterisation and immunogenicity questions. In practice, that kept compounding pharmacies from preparing BPC-157 for people.

What “kept off the bulks list” means. It is a restriction on compounding for human use , not a criminalisation of the molecule. It actually reinforces the research-use-only category rather than contradicting it. We cover the decision in depth in our 2023 FDA peptide compounding explainer.

July 2026: BPC-157 is back on the FDA’s agenda

The story did not end in 2023. On July 23, 2026, the FDA’s Pharmacy Compounding Advisory Committee is scheduled to discuss BPC-157 bulk drug substances again (free base and acetate), with ulcerative colitis listed as the evaluated use, as part of a fresh review of several peptide-related substances for potential 503A Bulks List consideration.

Importantly, this is still a compounding review, not a drug-approval decision and not a reversal of a criminal ban (there was none). Whatever the committee recommends, it would not by itself make BPC-157 an FDA-approved medicine. The full agenda is covered in our FDA peptide review 2026 overview, and the regenerative angle in our BPC-157 and TB-500 review.

Is BPC-157 banned in sport?

Here the word “banned” is accurate. The World Anti-Doping Agency (WADA) prohibits BPC-157 at all times under category S0 (non-approved substances) of its Prohibited List. Any athlete in a tested sport who uses it risks an anti-doping violation and sanctions, independent of the compound’s research-use status. If you compete under WADA or a national anti-doping code, treat BPC-157 as prohibited.

“Banned” vs “not approved”: a useful distinction

Much of the confusion comes from blurring two separate ideas:

Not FDA approved — BPC-157 has never been approved as a medicine. (See Is BPC-157 FDA approved?)

Not on the compounding bulks list — the 2023 decision kept it from human-use compounding.

Prohibited in sport — WADA bans it for tested athletes.

Research-use-only — it is still supplied to laboratories as a labelled reagent.

None of those is the same as a blanket criminal ban, and conflating them is exactly how “is BPC-157 banned?” turns into misinformation.

What this means if you research BPC-157

Treat BPC-157 as what it is: a research compound with an unsettled regulatory status and an active FDA review. Responsible suppliers position it for laboratory research use only, not for human consumption, and back it with a Certificate of Analysis. Be sceptical of any seller claiming BPC-157 is “FDA approved,” “unbanned,” or “cleared for human use” on the back of the 2026 meeting — none of those claims would be accurate.

Frequently Asked Questions

Is BPC-157 banned? Not as a scheduled/illegal substance. It is research-use-only; the FDA’s 2023 review kept it off the 503A Bulks List for human-use compounding, and WADA bans it in sport.

Did the FDA ban BPC-157 in 2023? The FDA kept it off the compounding bulks list for human use — a restriction on compounding, not a criminalisation of the molecule.

Could the July 2026 meeting “unban” it? It is a compounding-list review, not a criminal matter. Any recommendation would not make BPC-157 an approved medicine.

Buy BPC-157 from New-U Research Compounds

Lab-verified by Janoshik Analytical (RP-HPLC + ESI-MS), sealed vials, discreet tracked worldwide shipping. For laboratory research use only — not for human consumption.

Premium research peptides at >99% HPLC-verified purity, third-party tested by Janoshik Analytical with a Certificate of Analysis on every lot. Shipped lab-direct, discreet and cold-chain, worldwide. For laboratory research use only.

Research use only (RUO). All products are sold strictly for laboratory and research purposes — not for human or veterinary consumption. Purchasers must be 21 or older.

Website & business operated by Hilxera Distribution Services LLC. Registered in Wyoming, ID: 2026-001928701.

Research use only — not for human consumption. All products are supplied strictly for laboratory research purposes.

Is BPC-157 Banned? What the FDA Has and Hasn’t Done

BPC-157 is not a controlled substance

The 2023 FDA compounding decision (the real story behind “banned”)

July 2026: BPC-157 is back on the FDA’s agenda

Is BPC-157 banned in sport?

“Banned” vs “not approved”: a useful distinction

What this means if you research BPC-157

Frequently Asked Questions

Related Reading

From the Lab - Peptides on LinkedIn & Facebook

Lab-Verified Research Compounds

Buy BPC-157 from New-U Research Compounds

Shop

Learn

Company

Support

Ways to Pay

Shop by Compound

Shop by Goal

Ships worldwide